Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1203, pseudogene (RNU6-1203P) is a human pseudogene derived from the highly conserved U6 small nuclear RNA gene, typically found as one of many non-functional copies ("U6 snRNA pseudogenes") in the genome[5][2][6]. U6 small nuclear RNA is an essential component of the spliceosome, catalyzing intron removal from pre-mRNA[3][1]; however, the pseudogene form lacks biological activity and does not produce a functional RNA or protein product[5][6]. These U6-derived pseudogenes are considered genomic "fossils," thought to arise via retrotransposition rather than play a direct role in cell biology[6]. There is no evidence supporting a functional, disease-associated, or drug-interactable role for RNU6-1203P.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1203, pseudogene (RNU6-1203P).